AQR Capital Management
AGL icon

AQR Capital Management’s Agilon Health AGL Stock Holding History

AQR Capital Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.71M Buy
974,897
+566,426
+139% +$9.16M ﹤0.01% 1480
2025
Q4 		$7.03M Buy
408,471
+380,234
+1,347% +$7.37M ﹤0.01% 1380
2025
Q3 		$727K Buy
28,237
+152
+0.5% +$5.74K ﹤0.01% 2617
2025
Q2 		$1.61M Buy
28,085
+8,027
+40% +$644K ﹤0.01% 1914
2025
Q1 		$2.17M Buy
20,058
+14,215
+243% +$1.24M ﹤0.01% 1565
2024
Q4 		$278K Buy
5,843
+3,087
+112% +$187K ﹤0.01% 2526
2024
Q3 		$261K Sell
2,756
-51,502
-95% -$6.65M ﹤0.01% 2458
2024
Q2 		$8.87M Buy
54,258
+52,680
+3,338% +$7.5M 0.01% 792
2024
Q1 		$232K Buy
+1,578
New +$263K ﹤0.01% 2215

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return